Cellectis (CLLS) Shares Outstanding (Weighted Average) (2014 - 2026)

Cellectis' Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $5.9 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) changed 0.31% year-over-year to $5.9 billion; the TTM figure through Mar 2026 stood at $5.9 billion (changed 0.31% YoY), while the FY2025 annual figure was $60.0, down 100.0% from the prior year.
• Shares Outstanding (Weighted Average) was $5.9 billion for Q1 2026 at Cellectis, roughly flat from $5.9 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $42.0 billion in Q1 2022 to a low of $420.0 in Q2 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $5.2 billion across 5 years, with a median of $3.5 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) surged 311596.43% in 2023, then sank 100.0% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $45.7 million in 2022, then soared by 57.09% to $71.8 million in 2023, then soared by 39.5% to $100.1 million in 2024, then surged by 5797.46% to $5.9 billion in 2025, then rose by 0.25% to $5.9 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $5.9 billion (Q1 2026), $5.9 billion (Q4 2025), and $5.9 billion (Q3 2025), per Business Quant data.